Literature DB >> 12808066

Basal cell hyperplasia in the peripheral zone of the prostate.

Phataraporn Thorson1, Paul E Swanson, Robin T Vollmer, Peter A Humphrey.   

Abstract

Basal cell hyperplasia in the prostate is often viewed as a transition zone proliferation, related to usual, nodular glandular, and stromal hyperplasia. Basal cell hyperplasia in the prostatic peripheral zone, the most common site for development of prostatic intraepithelial neoplasia and carcinoma, has not been previously characterized. We characterized the incidence and histomorphological attributes of basal cell hyperplasia in a series of 500 consecutive sextant needle core biopsy samples and in 26 completely embedded prostate glands from radical prostatectomy specimens. Comparative proliferation indices (by MIB-1 staining) and apoptotic indices (by TUNEL labeling) were quantitated for peripheral zone versus transition zone basal cell hyperplasia versus normal basal cells. The incidence of basal cell hyperplasia in prostate needle biopsy tissue was 10.2% (51 of 500 cases). Usual basal cell hyperplasia was detected in 8.2% of the 500 cases, and basal cell hyperplasia with prominent nucleoli, in 2.0% of cases. Basal cell hyperplasia in needle biopsy tissue was typically focal and associated with inflammation, which was usually lymphocytic, in 84% of cases. Peripheral zone basal cell hyperplasia was found in 23% of whole prostate glands. Peripheral zone basal cell hyperplasia was not observed to be in direct physical continuity with intraepithelial or invasive neoplasia. Peripheral zone and transition zone basal cell hyperplasia exhibited similar mean proliferation and apoptotic indices, at 1% and 0.07%, respectively. This proliferation index was elevated, and apoptotic index was decreased, relative to normal basal cells (P = 1 x 10(-7)). Basal cell hyperplasia in the peripheral zone is present in a significant minority of prostate needle biopsy samples and whole prostate glands. The presence of prominent nucleoli in basal cell hyperplasia may cause diagnostic concern for a neoplastic proliferation. The increase in cell number in basal cell hyperplasia appears to be due to a coordinate increase in proliferation index coupled with a diminished apoptotic index. The presence of inflammation in the majority of basal cell hyperplasia foci suggests that peripheral zone basal cell hyperplasia in untreated patients may represent a stereotyped response to injury such as that sustained because of inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808066     DOI: 10.1097/01.MP.0000073526.59270.6E

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

Review 1.  Targeting phenotypic heterogeneity in benign prostatic hyperplasia.

Authors:  Douglas W Strand; Daniel N Costa; Franto Francis; William A Ricke; Claus G Roehrborn
Journal:  Differentiation       Date:  2017-08-04       Impact factor: 3.880

Review 2.  The benign mimickers of prostatic acinar adenocarcinoma.

Authors:  Yuqiao Xu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Zhe Wang; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

3.  Suppression of Tak1 promotes prostate tumorigenesis.

Authors:  Min Wu; Lihong Shi; Adela Cimic; Lina Romero; Guangchao Sui; Cynthia J Lees; J Mark Cline; Darren F Seals; Joseph S Sirintrapun; Thomas P McCoy; Wennuan Liu; Jin Woo Kim; Gregory A Hawkins; Donna M Peehl; Jianfeng Xu; Scott D Cramer
Journal:  Cancer Res       Date:  2012-03-30       Impact factor: 12.701

4.  Molecular pathogenesis of human prostate basal cell hyperplasia.

Authors:  Gervaise Henry; Alicia Malewska; Ryan Mauck; Jeffrey Gahan; Ryan Hutchinson; Jose Torrealba; Franto Francis; Claus Roehrborn; Douglas Strand
Journal:  Prostate       Date:  2017-08-10       Impact factor: 4.104

5.  Re-epithelialization resulted from prostate basal cells in canine prostatic urethra may represent the ideal healing method after two-micron laser resection of the prostate.

Authors:  Ying Cao; Guang-Heng Luo; Lei Luo; Xiu-Shu Yang; Jian-Xin Hu; Hua Shi; Ping Huang; Zhao-Lin Sun; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2015 Sep-Oct       Impact factor: 3.285

6.  Histopathological spectrum of 364 prostatic specimens including immunohistochemistry with special reference to grey zone lesions.

Authors:  Monika Garg; Gurmeen Kaur; Vineeta Malhotra; Ravish Garg
Journal:  Prostate Int       Date:  2013-12-30

7.  High Keratin-7 Expression in Benign Peri-Tumoral Prostatic Glands Is Predictive of Bone Metastasis Onset and Prostate Cancer-Specific Mortality.

Authors:  Charles Dariane; Sylvie Clairefond; Benjamin Péant; Laudine Communal; Zhe Thian; Véronique Ouellet; Dominique Trudel; Nazim Benzerdjeb; Feryel Azzi; Arnaud Méjean; Marc-Olivier Timsit; Manon Baurès; Jacques-Emmanuel Guidotti; Vincent Goffin; Pierre I Karakiewicz; Anne-Marie Mes-Masson; Fred Saad
Journal:  Cancers (Basel)       Date:  2022-03-23       Impact factor: 6.639

8.  Low grade urothelial carcinoma mimicking basal cell hyperplasia and transitional metaplasia in needle prostate biopsy.

Authors:  Julian Arista-Nasr; Braulio Martinez-Benitez; Leticia Bornstein-Quevedo; Elizmara Aguilar-Ayala; Claudia Natalia Aleman-Sanchez; Raul Ortiz-Bautista
Journal:  Int Braz J Urol       Date:  2016 Mar-Apr       Impact factor: 1.541

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.